House Panel Advances Transparency, Medicare Advantage, and Drug Bills

The House subcommittee advanced 15 health-related bills, enhancing price transparency and Medicare oversight.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here